Gary C. Cupit
Direttore/Membro del Consiglio presso Rheologics, Inc.
Profilo
Gary C.
Cupit was the founder of Somnus Therapeutics, Inc. founded in 2007, where he held the title of Chief Executive Officer in 2010.
He is currently a Director at Rheologics, Inc. Dr. Cupit's former positions include President & Chief Executive Officer at Sapphire Therapeutics, Inc., Vice President at The Medicines Co. and Novartis Corp., Faculty Member at the University of Pennsylvania, New York Hospital, the University of California, Berkeley, and the University of Tennessee, President at Enzo Therapeutics, Inc., and Principal at Smithkline Beecham Plc and Knoll Pharmaceutical Co. Dr. Cupit's education includes a doctorate from the University of the Sciences in Philadelphia and an undergraduate degree from the Medical College of Virginia.
Posizioni attive di Gary C. Cupit
| Società | Posizione | Inizio |
|---|---|---|
Rheologics, Inc.
 Rheologics, Inc. Miscellaneous Commercial ServicesCommercial Services Rheologics, Inc. provides research and development services. The company provides cardiovascular diagnostic and therapeutic products and services. Its services include tube technology, advanced microprocessors and proprietary algorithms, video microscope that enables clinicians to monitor changes in human blood microcirculation. Rheologics was founded by Kenneth R. Kensey in 1997 and is headquartered in Exton, PA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Gary C. Cupit
| Società | Posizione | Fine |
|---|---|---|
| Enzo Therapeutics, Inc. | Presidente | 16/01/2008 |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | - |
| University of Tennessee | Corporate Officer/Principal | - |
| University of Pennsylvania | Corporate Officer/Principal | - |
| University of California, Berkeley | Corporate Officer/Principal | - |
Formazione di Gary C. Cupit
| Medical College of Virginia | Undergraduate Degree |
| University of the Sciences in Philadelphia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Health Technology |
| Enzo Therapeutics, Inc. | |
Somnus Therapeutics, Inc.
 Somnus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Somnus Therapeutics, Inc. operates as a pharmaceutical company. It develops therapeutics to address the need of insomnia patients. The company was founded by Gary C. Cupit in June 2007 is headquartered in Branchburg, NJ. | Health Technology |
Rheologics, Inc.
Rheologics, Inc. Miscellaneous Commercial ServicesCommercial Services Rheologics, Inc. provides research and development services. The company provides cardiovascular diagnostic and therapeutic products and services. Its services include tube technology, advanced microprocessors and proprietary algorithms, video microscope that enables clinicians to monitor changes in human blood microcirculation. Rheologics was founded by Kenneth R. Kensey in 1997 and is headquartered in Exton, PA. | Commercial Services |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
| Knoll Pharmaceutical Co. | |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
New York Hospital
 New York Hospital Hospital/Nursing ManagementHealth Services New York Hospital is a healthcare company that operates hospitals, nursing homes, and ambulatory care centers. The private company is based in Flushing, NY and has subsidiaries in the United States. | Health Services |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
- Borsa valori
- Insiders
- Gary C. Cupit
